Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cryoablation of Venous Vascular Malformations

NCT: NCT01845935 · COMPLETED

NCT IDNCT01845935
StatusCOMPLETED
Start Date2013-04
Completion2015-08

Brief Summary

To now, two alternatives for the management of venous vascular malformations are recognized, appropriate to the location, size and patients: sclerosis and surgery. However, sclerosis is effective on symptoms in 80% of cases and excision removes the malformation completely or partially, but it is aggressive and recurrences are common.

Frequently Asked Questions

What is Cryoablation of Venous Vascular Malformations?

Cryoablation of Venous Vascular Malformations is a clinical trial registered under NCT01845935. Current status: COMPLETED.

What is the status of NCT01845935?

The current status of NCT01845935 (Cryoablation of Venous Vascular Malformations) is: COMPLETED.

When did Cryoablation of Venous Vascular Malformations start?

Cryoablation of Venous Vascular Malformations started on 2013-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.